| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Allografting for indolent lymphoid neoplasms
|
Toze, C. L.
|
|
2000
|
11 |
supplement-1 |
p. 59-61
|
article
|
| 2 |
A Randomised British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma
|
Linch, D. C.
|
|
2000
|
11 |
supplement-1 |
p. 87-90
|
article
|
| 3 |
A T-cell epitope determined with random peptide libraries and combinatorial peptide chemistry stimulates T cells specific for cutaneous T-cell lymphoma
|
Linnemann, T.
|
|
2000
|
11 |
supplement-1 |
p. 95-99
|
article
|
| 4 |
Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons
|
Hutchison, R. E.
|
|
2000
|
11 |
supplement-1 |
p. 35-38
|
article
|
| 5 |
Cutaneous lymphomas: A proposal for a unified approach to classification using the R.E.A.L./WHO Classification
|
Jaffe, E. S.
|
|
2000
|
11 |
supplement-1 |
p. 17-21
|
article
|
| 6 |
Diagnosis and treatment of transplant-related lymphoma
|
Swinnen, L. J.
|
|
2000
|
11 |
supplement-1 |
p. 45-48
|
article
|
| 7 |
Diffuse large-cell lymphoma
|
Fisher, R. I.
|
|
2000
|
11 |
supplement-1 |
p. 29-33
|
article
|
| 8 |
Distribution of various subtypes of non-Hodgkin's lymphoma in India: A study of 2773 lymphomas using R.E.A.L. and WHO Classifications
|
Naresh, K. N.
|
|
2000
|
11 |
supplement-1 |
p. 63-67
|
article
|
| 9 |
EORTC Classification for primary cutaneous lymphomas: A comparison with the R.E.A.L. Classification and the proposed WHO Classification
|
Willemze, R.
|
|
2000
|
11 |
supplement-1 |
p. 11-15
|
article
|
| 10 |
18–FDG-PET for the assessment of residual masses on CT following treatment of lymphomas
|
Mikhaeel, N. G.
|
|
2000
|
11 |
supplement-1 |
p. 147-150
|
article
|
| 11 |
Follicular lymphoma: Have we made any progress?
|
Horning, S. J.
|
|
2000
|
11 |
supplement-1 |
p. 23-27
|
article
|
| 12 |
Humanized anti-CD20 monoclonal antibody (Rituximab) in post transplant B-lymphoproliferative disorder: A retrospective analysis on 32 patients
|
Milpied, N.
|
|
2000
|
11 |
supplement-1 |
p. 113-116
|
article
|
| 13 |
Lymphoma classification – from controversy to consensus: The R.E.A.L. and WHO Classification of lymphoid neoplasms
|
Harris, N. L.
|
|
2000
|
11 |
supplement-1 |
p. 3-10
|
article
|
| 14 |
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: Update of the MDACC series
|
López-Guillermo, A.
|
|
2000
|
11 |
supplement-1 |
p. 137-140
|
article
|
| 15 |
Non-Hodgkin's lymphoma and occupational exposure to chemicals in Canada
|
Mao, Y.
|
|
2000
|
11 |
supplement-1 |
p. 69-73
|
article
|
| 16 |
Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): Experience from the BFM trials
|
Seidemann, K.
|
|
2000
|
11 |
supplement-1 |
p. 141-145
|
article
|
| 17 |
Primary cerebral lymphomas: Unsolved issues regarding first-line treatment, follow-up, late neurological toxicity and treatment of relapses
|
Blay, J.-Y.
|
|
2000
|
11 |
supplement-1 |
p. 39-44
|
article
|
| 18 |
Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myeloma
|
Chesi, M.
|
|
2000
|
11 |
supplement-1 |
p. 131-135
|
article
|
| 19 |
Stem-cell transplantation for chronic lymphocytic leukemia: The 1999 perspective
|
Dreger, P.
|
|
2000
|
11 |
supplement-1 |
p. 49-53
|
article
|
| 20 |
T-cell receptors for cytokines: Targets for immunotherapy of leukemia/lymphoma
|
Waldmann, T. A.
|
|
2000
|
11 |
supplement-1 |
p. 101-106
|
article
|
| 21 |
The ATM gene in the pathogenesis of mantle-cell lymphoma
|
Stilgenbauer, S.
|
|
2000
|
11 |
supplement-1 |
p. 127-130
|
article
|
| 22 |
The CUP trial: A randomized study analyzing the efficacy of high dose therapy and purging in low-grade non-Hodgkin's lymphoma (NHL)
|
Schouten, H. C.
|
|
2000
|
11 |
supplement-1 |
p. 91-94
|
article
|
| 23 |
The effect of Rituximab on patients with follicular and mantle-cell lymphoma
|
Ghielmini, M.
|
|
2000
|
11 |
supplement-1 |
p. 123-126
|
article
|
| 24 |
The role of high-dose chemotherapy in the treatment of multiple myeloma: A controversy
|
Kyle, R. A.
|
|
2000
|
11 |
supplement-1 |
p. 55-58
|
article
|
| 25 |
The seventh Lugano conference – basic science, translational and clinical research in the lymphoma field: The challenge goes on
|
Zucca, E.
|
|
2000
|
11 |
supplement-1 |
p. 1-2
|
article
|
| 26 |
Translocation t(14;18) in healthy individuals: Preliminary study of its association with family history and agricultural exposure
|
Paltiel, O.
|
|
2000
|
11 |
supplement-1 |
p. 75-80
|
article
|
| 27 |
Treatment of Hodgkin's disease: Results and current concepts of the German Hodgkin's Lymphoma Study Group
|
Sieber, M.
|
|
2000
|
11 |
supplement-1 |
p. 81-85
|
article
|
| 28 |
Treatment of mantle-cell lymphoma with Rituximab (chimeric monoclonal anti-CD20 antibody): Analysis of factors associated with response
|
Foran, J. M.
|
|
2000
|
11 |
supplement-1 |
p. 117-121
|
article
|
| 29 |
Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigens
|
Treon, S. P.
|
|
2000
|
11 |
supplement-1 |
p. 107-111
|
article
|
Journal description